ME
SOLV icon

McIlrath & Eck’s Solventum SOLV Stock Holding History

McIlrath & Eck’s Portfolio SOLV Stock Details SOLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.62K Buy
86
+2
+2% +$149 ﹤0.01% 1191
2025
Q4 		$6.66K Sell
84
-5
-6% -$383 ﹤0.01% 733
2025
Q3 		$6.5K Hold
89
– – ﹤0.01% 711
2025
Q2 		$6.75K Hold
89
– – ﹤0.01% 670
2025
Q1 		$6.77K Hold
89
– – ﹤0.01% 665
2024
Q4 		$5.88K Sell
89
-5
-5% -$350 ﹤0.01% 726
2024
Q3 		$6.55K Sell
94
-8
-8% -$481 ﹤0.01% 704
2024
Q2 		$5.39K Buy
+102
New +$6.19K ﹤0.01% 705

Other funds holding SOLV

IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TFM
Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

McIlrath & Eck's SOLV Position: Q1 2026 in Review

McIlrath & Eck increased its Solventum (SOLV) stake by 2.4% in Q1 2026, buying an estimated $149 and bringing the position to 86 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

McIlrath & Eck first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $6.77K in Q1 2025. 885 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • McIlrath & Eck held 86 shares of Solventum worth $5.62K as of Q1 2026.
  • McIlrath & Eck bought 2 Solventum shares in Q1 2026, an estimated $149.
  • Solventum made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1191 holding.
  • McIlrath & Eck first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • McIlrath & Eck's Solventum position peaked at $6.77K in Q1 2025.
  • 885 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.